The leaders of Gingko Bioworks and the BIO organization discuss the future of biological technologies, from developing vaccines faster to changing how we produce food.
Insights on Pharmaceuticals & Medical Products
Medtech companies could play a major role in the digital transformation of healthcare that is under way, but they will have to make some big changes to the way they operate—and fast.
Even in tough times, investor expectations and deal making in biotech are surging. Can the sector maintain its strong growth?
Advanced analytics will transform cancer care, but companies have been slow to adopt it. Progress requires a strategy that not only builds data and talent but also embraces experimentation.
The smart quality approach allows pharma companies to digitize, automate, and integrate their quality controls, making them faster, more effective, and more efficient.
For decades, private companies, investors, and public-health leaders have taken a pass on domestic vaccine manufacturing. But a confluence of circumstances may be changing the calculation.
Employers can consider a set of actions that supports COVID-19-vaccine adoption among employees by building conviction and making vaccination as convenient and “costless” as possible.
Santen CIO Minori Hara explains how IT is enabling the ophthalmological company to deliver a holistic sense of well-being around eye health.
Key stakeholders will need to continue to monitor and adapt to new data and new variants emerging across the globe to respond effectively.
Increasingly, small biopharmaceutical companies are launching their new drugs themselves rather than relying on large pharma companies to do it for them. How can they get it right the first time?